http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007097301-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3ec45e62175277459ff8c2be490f82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3928f66bb2545a8175c61c56146b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37d9115813fb41718c241ffb95f518d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0fff79ad40d7c00d47fafd35ff6cd75
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
filingDate 2007-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb548ef5b14ae85db686d3409481c3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0325152e19504c24c01c19afe166f267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d56556902037d6e841dcd54a22cc33
publicationDate 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007097301-A1
titleOfInvention Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
abstract Disclosed is a prophylactic or therapeutic agent for cerebral ischemia injury or cerebral ischemic reperfusion injury occurring in stroke such as cerebral infarction or cerebral hemorrhage, which develops its efficacy through a mechanism different from those of conventional ones and can be administered over a long period. The prophylactic or therapeutic agent comprises 6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2- carboxamide as an active ingredient. Particularly preferably, the compound is fidarestat, which is an optically resolved form having a (2S,4S) configuration.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011087066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011136161-A1
priorityDate 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09316003-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04173791-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002370984-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006090699-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4021
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447960959
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25619
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403426
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549120
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16227
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432693
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5RF29
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8SSK6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421441016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732693
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55FL3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243477353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100128998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9283
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07943
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16116
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100008445
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396424
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP38715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67202293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489193
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6IMN8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5RJP0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227452610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45377
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO08782
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449488
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449156
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3349
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MHY7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65673
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425701257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451783488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129752
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160024
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54NZ7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129551706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5724
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04185

Total number of triples: 89.